在患有免疫性血小板缺血症的患者中管理抗血小板治疗
Rosa Sonja Alesci1, Oliver Meyer2, Hanno Riess3
1MVZ IMD GmbH, Blood Coagulation Centre Hochtaunus, Bad Homburg, Germany.
Oncology research and treatment
|June 15, 2025
概括
免疫性血栓缩 (ITP) 的抗凝固治疗是复杂的. 血小板数超过50 × 10 ^ 9 / L通常是安全的,但其他因素影响ITP患者的决定.
科学领域:
- 血液学 血液学 血液学
- 心血管医学 心血管医学
背景情况:
- 越来越多的患者需要心血管疾病的抗凝固药.
- 缺乏详细的指导方针和研究,用于免疫性血栓缩 (ITP) 的抗凝剂.
- 在临床试验中,将ITP患者排除在抗凝血研究之外,反之亦然.
研究的目的:
- 探索ITP患者抗凝治疗的首选管理方法.
- 在临床实践中确定影响抗凝固决策的因素.
主要方法:
- 对德国,奥地利和瑞士的235名医疗专业人员进行调查.
- 介绍常见的患者场景,以引出决策因素.
- 专注于ITP患者抗凝剂的首选管理.
主要成果:
- 55%的受访者每月治疗5-10名ITP患者.
- 在大多数情况下,建议血小板计数为50 × 10 ^ 9 / L,用于抗凝剂.
- 实践模式的显著变化;心理社会地位是一个重要的因素.
结论:
- 在ITP患者中,抗凝血的决定是具有挑战性的.
- 血小板计数>50 × 10^9/L被认为是安全的;较低的计数需要考虑出血风险,并发症和心理社会状况.
- 需要基于证据的指导方针和以患者为中心的讨论,以优化治疗.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Venous Thrombosis IV: Nursing Management
27
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
27
Myocarditis III: Medical Management
20
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
20
Myocarditis IV: Nursing Management
40
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
40
Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932
Endocarditis III: Medical Management
26
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
26


